» Articles » PMID: 26932287

Novel Aspects in the Pathophysiology of Peripheral Vasculopathy in Systemic Sclerosis

Overview
Specialty Rheumatology
Date 2016 Mar 3
PMID 26932287
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic sclerosis (SSc) is a multisystem connective tissue disease characterized by fibrosis, autoimmunity and vascular damage. Although fibrosis is often considered the main feature of the disease, there is evidence that the underlying vasculopathy plays an important role in the initiation and perpetuation of SSc. Vascular manifestations such as Raynaud's phenomenon and digital ulcers are prominent in early disease stages and might substantially contribute to the SSc related mortality in later disease stages when pulmonary arterial hypertension becomes clinically evident. Vascular damage is thought to start with endothelial cell injury and apoptosis resulting in tissue hypoxia. Hypoxia is considered a main stimulus for vascular regenerative processes. However, despite the significant deterioration in number and quality of microvessels, there is a lack of appropriate compensatory repair processes by angiogenesis and vasculogenesis. In this review, we will discuss recent data about the pathophysiology of peripheral (acral) microvascular damage in SSc, highlight novel aspects behind the defective repair mechanisms in the vascular system in SSc and focus on SSc animal models with peripheral vascular changes.

Citing Articles

Orofacial Complications of the Connective Tissue Disease Systemic Sclerosis.

Sharma M, Fadl A, Leask A J Dent Res. 2024; 103(7):689-696.

PMID: 38779873 PMC: 11191658. DOI: 10.1177/00220345241249408.


The Association of Telangiectasias with Other Peripheral Vascular Lesions of Systemic Sclerosis.

Bobeica C, Niculet E, Musat C, Iancu L, Craescu M, Luca A Clin Cosmet Investig Dermatol. 2024; 17:211-218.

PMID: 38292323 PMC: 10826706. DOI: 10.2147/CCID.S432422.


Anti-vinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc cohorts.

Suliman Y, Kafaja S, Oh S, Alemam M, Bagnato G, Abignano G Clin Rheumatol. 2020; 40(6):2277-2284.

PMID: 33231773 DOI: 10.1007/s10067-020-05479-5.


Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) definition.

Suliman Y, Bruni C, Johnson S, Praino E, Alemam M, Borazan N J Scleroderma Relat Disord. 2018; 2(2):115-120.

PMID: 30569018 PMC: 6296474. DOI: 10.5301/jsrd.5000236.


Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release.

Benyamine A, Magalon J, Sabatier F, Lyonnet L, Robert S, Dumoulin C Front Immunol. 2018; 9:1665.

PMID: 30072999 PMC: 6058015. DOI: 10.3389/fimmu.2018.01665.